Work

Phase II trial of bintrafusp alfa in patients with metastatic MSI-H cancers following progression on immunotherapy.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.3_suppl.79

Authors: Van K. Morris, Michael Lam, Xuemei Wang, Michael J. Overman, Benny Johnson, Bryan K. Kee, Robert A. Wolff, Arvind Dasari, Isabel R. Zorrilla, Alda Tam, Dipen M. Maru, Scott Kopetz

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, EMD Serono

OpenAlex ID: W3124882043

Cites:

Cited by: 17

Related to: 10